ALIVE Israel HealthTech Fund is a pioneering mid-to-late stage HealthTech fund that focuses on optimizing value creation in the healthcare industry. They leverage an exclusive ecosystem of strategic partners, including leading hospital chains, HMOs, and financial institutions, to support and accelerate the growth of their portfolio companies. With a strong emphasis on collaboration, optimization, and execution, ALIVE aims to drive HealthTech companies from business plans to successful business outcomes.

Their unique strategic ecosystem and active engagement help portfolio companies achieve large-scale success. ALIVE provides unparalleled access to resources such as clinical infrastructures, key opinion leaders (KOLs), big data, domain experts, and financial backing. This allows their companies to gain in-depth understanding of clinical workflows and procedures, ensuring product-market fit in challenging health economics and delivering better care for patients.

Backed by 60 years of combined experience, ALIVE has a $150M investment fund and evaluates approximately 800 prospective companies annually. They invest in promising mid-to-late stage companies developing innovative platform technologies in various disciplines, including medical devices, diagnostics, digital health, healthcare IT, artificial intelligence (AI), and machine learning (ML). ALIVE seeks highly fundable companies with strong management, broad IP protection, and a proven track record of execution that can benefit from the strategic synergies offered by their ecosystem.

To learn more about ALIVE Israel HealthTech Fund, you can contact them via email at info@alivevc. com or phone at +972-52-8784778. Their office is located at 1 HaShikma St, Savyon, 1st Floor, Building C, 5651801